ResearcherEge UniversityActive in the last 2 years

DeryaIlem-Ozdemir

Verified by OpenAlex author ID (good confidence)As of 11 November 2026

Matched on OpenAlex author ID A5119498685.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2026: 2 papers

Papers 2

Synthesis and Preclinical Evaluation of a Novel [225Ac]Ac-PEG6-Macropa-PAM4 for Targeted Alpha Therapy of Pancreatic Cancer. Last author DOI 10.1007/s13139-026-01010-x ↗
Mesothelin-targeted alpha therapy in PDAC with [225Ac]Ac-Macropa-PEG6-Amatuximab. Last author DOI 10.1016/j.nucmedbio.2026.109606 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Madeeha Shabnam · 2 shared papers, 2026
- Paper Synthesis and Preclinical Evaluation of a Novel [225Ac]Ac-PEG6-Macropa-PAM4 for Targeted Alpha Therapy of Pancreatic Ca… DOI 10.1007/s13139-026-01010-x ↗
- Paper Mesothelin-targeted alpha therapy in PDAC with [225Ac]Ac-Macropa-PEG6-Amatuximab. DOI 10.1016/j.nucmedbio.2026.109606 ↗
Syed Sibtain Hussain Shah · 1 shared paper, 2026
- Paper Mesothelin-targeted alpha therapy in PDAC with [225Ac]Ac-Macropa-PEG6-Amatuximab. DOI 10.1016/j.nucmedbio.2026.109606 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.